Sign a strategic cooperation agreement with Russian clients. Products | Shenzhou

Liaoyang Shenzhou Machinery and Russian Customer Strategic Cooperation Agreement Report: Jointly Developing the Russian Animal Blood Market

1、 Introduction

（1） Background of cooperation

With the booming development of global animal medicine, scientific research, and related industries, the animal blood market is showing a strong growth trend. As a country with a large livestock industry and an active research environment, Russia's demand for the collection, processing, and application of animal blood is increasing day by day. According to a report by Research and Markets, the global animal diagnostics market is expected to reach $50.66 billion by 2028, with a compound annual growth rate of approximately 7.4%. Russia, as an important regional market, has enormous potential in the animal blood related niche market.

Since its establishment on April 10, 2018, Liaoyang Shenzhou Machinery has accumulated rich experience in the field of mechanical equipment manufacturing, especially in the research and production of separation equipment such as centrifuges. The company is located in Liaoyang City, Liaoning Province, with advanced production equipment, a professional technical team, and has passed ISO9001 quality system certification. Its products cover more than 20 varieties in five categories and are widely used in various industries such as pharmaceuticals, food, and biology, including animal medicine and scientific research. Russian customers occupy an important position in the supply chain of animal medicine, scientific research, and related industries in Russia, with a wide customer network, deep market resources, and precise understanding of local regulations, policies, and market demands. In this context, both parties have decided to work together to jointly explore the Russian animal blood market.

（2） Purpose and significance of cooperation

Purpose of Cooperation

In response to the diverse needs of the Russian animal blood market, we have jointly developed a series of professional animal blood processing equipment and complete solutions, such as centrifuges suitable for separating blood from different animal species, high-precision blood component extraction equipment, etc., to ensure that our products meet the strict requirements of the Russian market in terms of performance, quality, and applicability.

By leveraging the market channels and resource advantages of Russian customers, we will quickly and effectively introduce Liaoyang Shenzhou Machinery's products into the Russian animal blood market, significantly increasing the market awareness and coverage of our products in the early stages of cooperation, and gradually achieving steady growth in market share.

Establish a long-term, stable, and mutually beneficial strategic partnership, continuously optimize products and services through technical exchanges, market feedback collection and analysis, establish an excellent brand image in the Russian animal blood market, and become a trusted animal blood processing equipment supplier for local customers.

Significance of cooperation

For Liaoyang Shenzhou Machinery, this cooperation is an important opportunity to expand its international market territory and enhance its international competitiveness. Being able to gain a deep understanding of the demand characteristics in the Russian market, promote advanced technology and high-quality products to broader overseas markets, increase international business revenue, accumulate valuable international operational experience, and lay a solid foundation for further expanding into other global markets.

By cooperating with Liaoyang Shenzhou Machinery, Russian customers can introduce international advanced animal blood processing equipment manufacturing technology and products, enrich their own business product lines, enhance their service capabilities and market competitiveness in the local animal medical, scientific research, and related industries in Russia, further consolidate and expand their leading position in the local market, and obtain more business opportunities and economic benefits.

From the perspective of the overall development of Russia's animal medical and scientific research industry, the strategic cooperation between the two sides will help improve the technological level and product quality of animal blood processing equipment in Russia, thereby improving the quality of animal medical services, promoting the efficient development of animal research projects, providing strong support for the healthy development of Russia's animal husbandry industry, animal disease prevention and control, and scientific research innovation, and promoting the comprehensive progress of Russia's animal related industries.

2、 Overview of Strategic Cooperation

（1） Collaboration mode

Joint R&D cooperation: Both parties jointly establish a professional joint R&D team, invest funds, technology, and human resources, and conduct in-depth research on the unique needs and future development trends of the Russian animal blood market. Liaoyang Shenzhou Machinery, with its professional capabilities in equipment manufacturing technology, process research and development, is responsible for providing core technical support and leading the design and development of equipment. Russian clients utilize their in-depth understanding of the local market to provide feedback on market demand, usage habits of animal medicine and research institutions, and participate in the optimization process of product design to ensure that research and development results closely meet the actual needs of the Russian market.

Market promotion and sales cooperation: Russian customers fully utilize their extensive sales network, rich customer resources, and strong marketing channels in Russia to be fully responsible for the sales and promotion of Liaoyang Shenzhou Mechanical Animal Blood Processing products in the Russian market. Liaoyang Shenzhou Machinery provides product training, technical support, and other assistance for sales and promotion activities. Both parties jointly plan and hold product promotion events, participate in various animal medical and scientific research industry exhibitions in Russia, and other market activities to enhance the product's visibility and influence in the Russian market. At the same time, both parties will establish a real-time sharing mechanism for sales information, communicate market sales situation in a timely manner, and flexibly adjust sales strategies.

After sales and technical service cooperation: jointly build a comprehensive after-sales technical service team to provide timely, efficient, and high-quality equipment repair, maintenance, technical consulting, and other services to Russian customers. Liaoyang Shenzhou Machinery is responsible for providing professional technical training to the Russian after-sales team to ensure their ability to independently carry out equipment maintenance and upkeep. Russian customers are responsible for the localized operation and daily management of the after-sales team, ensuring the timeliness and response quality of after-sales service. By building an after-sales service information platform, real-time tracking of equipment usage status, collecting customer feedback, and providing data basis for continuous product improvement.

（2） Areas of Cooperation

Animal blood centrifuge product field: Collaborative research and development of specialized blood centrifuges suitable for different application scenarios in Russian animal medicine, scientific research, etc. (such as animal hospitals, veterinary stations, animal research laboratories, etc.). On the basis of existing centrifuge product technology, optimize the centrifugal parameters and separation performance of the equipment according to the characteristics of different animal blood (such as different densities, viscosities, etc.), improve centrifugal efficiency and accuracy, and ensure the precise separation of various animal blood components. At the same time, considering the complex climate conditions in Russia, especially the cold winter, we have developed centrifuge products with cold resistance characteristics to ensure stable operation of equipment in low-temperature environments and extend its service life.

In the field of animal blood component separation equipment, we will jointly carry out the research and development of advanced animal blood component separation equipment, which can accurately separate red blood cells, white blood cells, platelets, and various plasma components in animal blood, to meet the needs of various aspects such as animal clinical treatment, animal vaccine production, animal disease diagnosis and scientific research in Russia. Based on the specific requirements and operating habits of Russian animal medical and scientific research institutions for blood component separation, optimize the operation process of equipment, improve separation purity and efficiency, reduce equipment operating costs, and enhance product cost-effectiveness.

In the field of supporting services and consumables: In addition to equipment research and development and sales, both parties have carried out in-depth cooperation in the field of supporting services and consumables. Develop specialized disposable consumables that are compatible with animal blood processing equipment, such as animal blood centrifuge tubes, blood component separation bags, etc., to ensure reliable quality of consumables, good compatibility with equipment, and compliance with relevant Russian health standards and regulatory requirements. At the same time, we provide value-added services such as equipment installation and debugging, operator training, equipment leasing, and equipment lifecycle maintenance, building a complete product service system and improving customer satisfaction.

（3） Cooperation period

This strategic cooperation agreement shall come into effect from the date of formal signing by both parties and shall be valid for a period of 5 years. Six months before the expiration of the cooperation period, both parties will conduct a comprehensive and in-depth evaluation of all work during the cooperation period. If both parties have no objections during the evaluation process, this agreement will automatically renew for 3 years. If one party decides not to renew the contract, they must give the other party a formal written notice three months in advance. During the cooperation period, both parties will adjust their cooperation strategies and implementation plans in a timely manner based on the dynamic changes in the Russian animal blood market, the actual progress of the cooperation project, and the industry's technological development trends, to ensure that the cooperation always maintains efficiency and sustainability.

• Year Established
  --
• Business Type
  --
• Country / Region
  --
• Main Industry
  --
• Main Products
  --
• Enterprise Legal Person
  --
• Total Employees
  --
• Annual Output Value
  --
• Export Market
  --
• Cooperated Customers
  --